# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-002408
Filing Date
2025-04-02
Accepted
2025-04-02 16:45:33
Documents
4
Period of Report
2025-04-02

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdef14-a.htm | DEF 14A | 239413
2 |  | formdef14-a_001.jpg | GRAPHIC | 18551
3 |  | proxy_001.jpg | GRAPHIC | 511995
4 |  | proxy_002.jpg | GRAPHIC | 697753
| Complete submission text file | 0001641172-25-002408.txt |  | 1932646

Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-27072 | Film No.: 25805554
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)